Please provide your email address to receive an email when new articles are posted on . The updated label shows safety and efficacy in treating moderate to severe atopic dermatitis of the hands or ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

More than 31 million Americans are living with eczema/ atopic dermatitis (AD), a chronic inflammatory skin condition that extends far beyond visible symptoms to disrupt sleep, mental health, and daily ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The significant burden imposed by AD on patients and the health care system includes increases in hospitalizations, health care costs, loss of work productivity, and disability. 9-14 This impact is ...

(Mass Appeal) – It’s that time of year, the summer humidity is waning, we’re turning on the heat in our homes and businesses, and all that means drier skin. One place on our bodies that exhibits dry ...

The MarketWatch News Department was not involved in the creation of this content. -- ADHAND is a phase 3b placebo-controlled clinical trial evaluating the efficacy and safety of tralokinumab in adult ...

But when you add being Black to the equation — and the racism and other forms of bias that come with it — those negative feelings can intensify. It’s common for Black people with atopic dermatitis to ...

Definition. Approximately 80% of all HD cases involve irritant contact dermatitis (ICD). Contact dermatitis of the hands can be either irritant or allergic in etiology (Goh, 1989). Irritants are ...

Gadgets are now a part of the everyday routine for us. Tablets, phones, and laptops not only tend to affect the posture and ...